Describing taste changes and their potential impacts on paediatric patients receiving cancer treatments

被引:7
作者
Loves, Robyn [1 ]
Green, Gloria [2 ,3 ]
Joseph-Frederick, Zakia [1 ]
Palmert, Sasha [1 ]
Plenert, Erin [1 ]
Schechter, Tal [3 ]
Tomlinson, Deborah [1 ]
Vettese, Emily [1 ]
Zahra, Serena [1 ]
Zupanec, Sue [3 ]
Dupuis, L. Lee [1 ,4 ]
Sung, Lillian [1 ,3 ]
机构
[1] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Child Hlth Evaluat Sci, Toronto, ON, Canada
[2] Hosp Sick Children, Div Clin Dietet, Toronto, ON, Canada
[3] Hosp Sick Children, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Hosp Sick Children, Leslie Dan Fac Pharm, Dept Pharm, Toronto, ON, Canada
关键词
cancer; paediatrics; symptoms and symptom management; quality of life; supportive care; CHEMOTHERAPY; CHILDREN; SMELL; PREVENTION; GUIDELINE;
D O I
10.1136/bmjspcare-2021-002951
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives Taste changes are common among paediatric patients receiving cancer treatments although specific descriptions and associations are uncertain. Primary objective was to describe the number of paediatric patients receiving cancer therapies who experienced taste changes, its impact on food intake and enjoyment of eating, and coping strategies. Methods This was a cross-sectional study that included English-speaking paediatric patients aged 4-18 years with a diagnosis of cancer or haematopoietic stem cell transplantation recipients receiving active treatment. Using a structured interview, we asked participants about their experience with taste changes, impacts and coping strategies. The respondent was the paediatric patient. Results We enrolled 108 patients; median age was 11 years (IQR 8-15). The taste changes reported yesterday or today were food tasting bland (34%), bad (31%), different (27%), bitter (25%), extreme (19%), metallic (15%) or sour (12%). Taste changes were associated with decreased food intake (31%) and decreased enjoyment in eating (25%) yesterday or today. The most common coping strategies were eating food they liked (42%), eating strong-tasting food (39%), drinking liquids (35%), brushing teeth (31%) and sucking on candy (25%). Factors significantly associated with food tasting bad were as follows: older age (p=0.003), shorter time since cancer diagnosis (p=0.027), nausea and vomiting (p=0.008) and mucositis (p=0.009). Conclusions Among paediatric patients receiving cancer treatments, taste changes were common and were associated with decreased food intake and enjoyment in eating. Common coping strategies were described. Reducing nausea, vomiting and mucositis may improve taste changes.
引用
收藏
页码:E382 / E388
页数:7
相关论文
共 50 条
[41]   Changes in Symptom Intensity Among Cancer Patients Receiving Outpatient Palliative Care [J].
Kang, Jung Hun ;
Kwon, Jung Hye ;
Hui, David ;
Yennurajalingam, Sriram ;
Bruera, Eduardo .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2013, 46 (05) :652-660
[42]   Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy [J].
Arpino, Grazia ;
De Angelis, Carmine ;
Buono, Giuseppe ;
Colao, Annamaria ;
Giuliano, Mario ;
Malgieri, Simona ;
Cicala, Stefania ;
De Laurentiis, Michelino ;
Accurso, Antonello ;
Crispo, Anna ;
Limite, Gennaro ;
Lauria, Rossella ;
Veneziani, Bianca Maria ;
Forestieri, Valeria ;
Bruzzese, Dario ;
De Placido, Sabino .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (01) :127-132
[43]   Correlation between changes in nutritional status and tumor response in patients receiving immunotherapy for lung cancer (NUTIMMUNO study) [J].
Mahe, Marie ;
Seegers, Valerie ;
Vansteene, Damien .
SUPPORTIVE CARE IN CANCER, 2024, 32 (05)
[44]   Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis [J].
Kurt, Berna ;
Oksuzoglu, Berna Omuer Cakmak .
CANCER CONTROL, 2025, 32 :10732748251363323
[45]   CHANGES IN THE GASTRIC POTENTIAL DIFFERENCE DURING CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER [J].
FABRIN, B ;
HOJGAARD, L ;
MOURIDSEN, HT .
ACTA ONCOLOGICA, 1991, 30 (07) :807-809
[46]   Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [J].
Berliere, Martine ;
Piette, Nathan ;
Bernard, Marion ;
Lacroix, Camille ;
Gerday, Amandine ;
Samartzi, Vasiliki ;
Coyette, Maude ;
Roelants, Fabienne ;
Docquier, Marie-Agnes ;
Touil, Nassim ;
Watremez, Christine ;
Piette, Philippe ;
Duhoux, Francois P. .
CANCERS, 2021, 13 (16)
[47]   Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments [J].
Jessica J. Hopkins ;
Michael B. Sawyer .
Cancer Chemotherapy and Pharmacology, 2018, 82 :1-29
[48]   Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments [J].
Hopkins, Jessica J. ;
Sawyer, Michael B. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) :1-29
[49]   Effect of Selective 5-Hydroxytryptamine-3 Receptor and Neurokinin-1 Receptor Antagonists on Hemodynamic Changes and Arrhythmogenic Potential in Patients Receiving Chemotherapy: A Retrospective, Observational Study [J].
Bozbulut, Utku Burak ;
Cengiz, Tugba ;
Ozet, Ahmet .
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
[50]   Heterogeneity of vulnerability and taste changes in older cancer patients undergoing chemotherapy: a latent class analysis [J].
Min Zhu ;
Teng Wang ;
Jun Sun ;
Zhou Zhou ;
Danhui Wang ;
Liping Teng .
Supportive Care in Cancer, 2023, 31